In one editorial, Cleveland Clinic cardiologist Eric Topol , who was the first to raise the alarm about Vioxx three years ago, calls for a formal government investigation into how Merck (nyse: MRK - news - people ) and the U.S. Food and Drug Administration left Vioxx on the market for so long after concerns about its possible heart risks had been raised.
FORBES: Top Doctor Calls For Vioxx Investigation